antibiotics Archives

3rdInternational Conference on Vaccines & Vaccination

Published on : May 20, 2020September 10, 2019 Published by : Chris Frew

Breakthrough in Vaccine 2020 Conference Event Name: 3rd International Conference Vaccines & Vaccination (Vaccine 2020)| May 20-21, 2020 Theme: Advances in Immunology & Vaccine Technology and Their Impact Aim and [….]

JLABS @ Washington, DC | UnMasked: We All Breathe – A Film Exploring the Dark Truth Behind MDR TB

Published on : November 20, 2019November 11, 2019 Published by : Chris Frew

Antimicrobial resistance (AMR) is in the news lately and for good reason. Diseases that were once easy to treat are becoming increasingly difficult to cure. But the largest contributor to [….]

MCEDC Interview: Greg Merril, CEO of Adaptive Phage Therapeutics

Published on : March 19, 2019March 19, 2019 Published by : Chris Frew

MCEDC Interview: Greg Merril, CEO of Adaptive Phage Therapeutics Adaptive Phage Therapeutics’ CEO, Greg Merril, was featured this week in MCEDC’s Built For Bio Video Series. David Petr, CEO of [….]

Adaptive Phage Therapeutics Hosts Book Launch Event for ‘The Perfect Predator’

Published on : March 6, 2019March 6, 2019 Published by : Chris Frew

IMAGE CREDIT: https://theperfectpredator.com Adaptive Phage Therapeutics Hosts Book Launch Event for ‘The Perfect Predator’ March 6, 2019 This past weekend marked the launch of ‘The Perfect Predator: A Scientist’s Race [….]

“In Conversation” with Mina Izadjoo, President of IPS

Published on : September 5, 2018September 5, 2018 Published by : Sarah Ellinwood

“In Conversation” with Mina Izadjoo, President of IPS In preparation for the upcoming CEO Talks Panel on Innovators Combating Drug Resistance, BioBuzz Contributor, Sarah Ellinwood, Ph.D. caught up with one [….]

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance

Published on : August 27, 2018October 10, 2018 Published by : Steven Surdez

Dr. Carol Nacy, CEO of Sequella, Takes on the Global Crisis of Anti-Microbial Resistance For Dr. Carol Nacy, co-founder and CEO of Rockville, Maryland’s clinical-stage antibiotics developer Sequella, it all [….]